Amster Labs Ltd - Stock Valuation and Financial Performance

BSE: 0 | NSE: | Pharmaceuticals & Drugs |

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Amster Labs

DeciZen not available for IPO

10 Year X-Ray of Amster Labs:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'24TTM
ROCE % 14.2%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 35.30
Sales YoY Gr.--
Adj EPS 4.30
YoY Gr.--
BVPS (₹) 12.40
Adj Net
Profit
5.8NAN
Cash Flow from Ops. 4.1-
Debt/CF from Ops. 9.8-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANANA
Adj EPS NANANANA
BVPSNANANANA
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'24TTM
Return on
Equity %
350
Op. Profit
Mgn %
23.4NAN
Net Profit
Mgn %
16.4NAN
Debt to
Equity
2.4-
Working Cap
Days
00
Cash Conv.
Cycle
00

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Amster Labs Ltd.

Standalone Consolidated
TTM EPS (₹) - -
TTM Sales (₹ Cr.) - -
BVPS (₹.) - -
Reserves (₹ Cr.) - -
P/BV - -
PE - -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) -
Equity (₹ Cr.) -
Face Value (₹) -
Industry PE -

Quarterly Results

 Mar'24 YoY Gr. Rt. %Jun'24 YoY Gr. Rt. %Sep'24 YoY Gr. Rt. %Dec'24 YoY Gr. Rt. %
Sales (₹ Cr.) 0.8 -26.90 -1000 -1000 -100
Adj EPS (₹) 0 -50-0.1 N/A-0.1 -220-0.1 N/A
Op. Profit Mgn % 1.45 -28 bps0.00 86 bps0.00 -202 bps0.00 -82 bps
Net Profit Mgn % 0.92 6 bps0.00 91 bps0.00 -176 bps0.00 -82 bps

Management X-Ray of Amster Labs:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Amster Labs

MRP
spaceLock icon
MOS
spaceLock icon%
DP
spaceLock icon
Base EPS
spaceLock icon
DPS
spaceLock icon
MRP: ₹ 0
DP: ₹0
Base EPS ₹:
DPS ₹:
MOS (%):
Expected EPS Growth Rate:
0%
Base 0%
50%
Expected Rate of Return:
0%
Base 0%
50%
Future PE:
0
Base 0
200
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max

Event Update

Login/Register to view analysis.

Analyst's Notes

No data found!

Key Ratios of Amster Labs

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Company Name CMP(₹)
Change ₹(%)
Market Cap
Net Sales (₹ Cr.)
Latest EPS (₹)
Net Profit Margin %
Latest P/E
Latest P/BV
Sun Pharma Inds. 1,687.6 35.5 (2.2%) Large Cap 48,497 47.7 20.9 34.7 5.5
Dr. Reddys Lab 1,109.2 14 (1.3%) Large Cap 28,011 64.4 19.6 17 2.8
Cipla 1,463.2 46.9 (3.3%) Large Cap 25,774 61.8 15.6 22.9 3.8
Lupin 1,969.1 47.8 (2.5%) Mid Cap 20,011 62.8 9.7 30.6 5.3
Zydus Lifesciences 868.3 23.7 (2.8%) Large Cap 19,547 45.1 19.3 18.7 3.7
Glenmark Pharma 1,377.6 0.7 (0.1%) Mid Cap 11,813 -6.2 -10.2 - 4.4
Torrent Pharma 3,127.5 1 (0%) Large Cap 10,728 55 14.8 56.8 13.2
Aurobindo Pharma 1,082.6 26.1 (2.5%) Mid Cap 10,646 33 17.2 32 3.1
Alkem Laboratories 4,880.4 42.5 (0.9%) Mid Cap 9,748 190.9 18.1 25.4 4.7
Mankind Pharma 2,351.3 37.1 (1.6%) Mid Cap 9,265 47.4 19.6 48.8 6.7
Shows rows:

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'24
Sales35.32
Operating Expenses 27.06
Manufacturing Costs0.75
Material Costs21.21
Employee Cost 3.36
Other Costs 1.74
Operating Profit 8.26
Operating Profit Margin (%) 23.4%
Other Income 0.18
Interest 0.82
Depreciation 0.41
Exceptional Items 0
Profit Before Tax 7.22
Tax 1.42
Profit After Tax 5.80
PAT Margin (%) 16.4%
Adjusted EPS (₹)4.3
Dividend Payout Ratio (%)0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'24

Equity and Liabilities

Shareholders Fund 16.55
Share Capital 7.43
Reserves 9.12
Minority Interest0
Debt37.05
Long Term Debt8.53
Short Term Debt28.51
Trade Payables40.70
Others Liabilities 16.34
Total Liabilities 110.63

Fixed Assets

Gross Block28.78
Accumulated Depreciation6.82
Net Fixed Assets21.96
CWIP 3.20
Investments 0
Inventories29.08
Trade Receivables49.72
Cash Equivalents 2.05
Others Assets4.63
Total Assets 110.63

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'24
Cash Flow From Operating Activity 4.08
PBT 7.22
Adjustment 0.98
Changes in Working Capital -5.12
Tax Paid 1
Cash Flow From Investing Activity -3.90
Capex -4.08
Net Investments 0
Others 0.18
Cash Flow From Financing Activity 1.45
Net Proceeds from Shares 4.75
Net Proceeds from Borrowing -0.50
Interest Paid -0.75
Dividend Paid 0
Others -2.04
Net Cash Flow 1.64
PARTICULARSMar'24
Ratios
ROE (%)35.04
ROCE (%)14.21
Asset Turnover Ratio0.32
PAT to CFO Conversion(x)0.7
Working Capital Days
Receivable Days514
Inventory Days300
Payable Days701

Amster Labs Ltd Stock News

No data found.

Amster Labs Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Amster Labs on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Amster Labs stood at ₹0.00.
The latest P/E ratio of Amster Labs as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of Amster Labs as of 01-Jan-1970 05:30 is 0.00.
The 52-week high of Amster Labs is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Amster Labs is ₹0.00 ( Cr.) .

About Amster Labs Ltd

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...